Chlorofluorocarbon-free mometasone furoate aerosol formulations
US6068832A · kind A · utility
22Cited by
6References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 27, 1997 |
| Grant date | May 30, 2000 |
| Priority date | — |
| Expiry date | Aug 27, 2017 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/58
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to suspension aerosol formulations which exhibit stable particle sizes, containing mometasone furoate, about 1 to about 10 weight percent ethanol and 1,1,1,2,3,3,3-Heptafluoropropane as the propellant. A surfactant, such as oleic acid, can also be included. These formulations are suitable for use in metered dose inhalers.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.